Skip to main content
SpringerLink
Log in
Book cover

Methods of Cancer Diagnosis, Therapy, and Prognosis

Liver Cancer

  • Book
  • © 2009

Overview

Editors:
  1. M. A. Hayat

    1. Department of Biological Sciences, Kean University, Union, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • The only book that discusses cancer diagnosis, therapy, and prognosis together in one volume
  • Discusses the molecular processes that lead to the development and proliferation of cancer cells
  • Includes recent major advances in cancer diagnosis and therapy assessment
  • The text is supported throughout with illustrations
  • The information in the book identifies patients with high likelihood of clinical benefits from a specific treatment

Part of the book series: Methods of Cancer Diagnosis, Therapy and Prognosis (HAYAT, volume 5)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (36 chapters)

  1. Hepatocellular Carcinoma

    1. A. Diagnosis

      1. Hepatocellular Cancer in Cirrhotic Patients: Radiological Imaging
        • Francesca Lodato, N. Davies, D. Yu, Andrew K. Burroughs
        Pages 261-273

  2. Metastases

    1. A. Diagnosis

      1. Liver Metastases from Colorectal Cancer: Ultrasound Imaging
        • Søren R. Rafaelsen
        Pages 355-367
      2. Preclinical Liver Metastases: Three-Dimensional High-Frequency Ultrasound Imaging
        • Kevin C. Graham, Lauren A. Wirtzfeld, James C. Lacefield, Ann F. Chambers
        Pages 369-386
      3. Colorectal Liver Metastases: 18F-Fluorodeoxyglucose-Positron Emission Tomography
        • Stéphanie Truant, Damien Huglo, François-René Pruvot
        Pages 387-406

  3. Biliary Cancer

    1. A. Diagnosis

      1. Biliary Cystic Tumors: Clinicopathological Features
        • Yasuni Nakanuma, Hiroko Ikeda, Yasunori Sato, Kenichi Harada, Koichi Nakamura, Yoh Zen
        Pages 411-428
      2. Cholangiocarcinoma: Intraductal Sonography
        • Kazuo Inui, Hironao Miyoshi, Junji Yoshino
        Pages 429-437

    2. B. Prognosis

      1. Extrahepatic Bile Duct Carcinoma: Role of the p53 Protein Family
        • Alexander I. Zaika, Seung-Mo Hong
        Pages 441-449
      2. Extrahepatic Bile Duct Carcinoma: Mucin 4, a Poor Prognostic Factor
        • Michiyo Higashi, Shugo Tamada, Kohji Nagata, Masamichi Goto, Suguru Yonezawa
        Pages 451-459

    3. C. Treatment

      1. Hilar Cholangiocarcinoma: Photodynamic Therapy and Stenting
        • Marcus Wiedmann, Joachim Mössner, Helmut Witzigmann
        Pages 463-483

  4. Splenic Cancer

    1. A. Diagnosis

      1. Splenic Metastases: Diagnostic Methods
        • Eva Compérat, Frédéric Charlotte
        Pages 489-497

  5. Back Matter

    Pages 499-514
    Download chapter PDF
Back to top

Keywords

About this book

This volume presents a detailed survey of imaging, multidetector-row computed t- various methodologies related to diagno- ography, helical computed tomography, sis, therapy, and prognosis of liver cancer, ultrasonography, and power Doppler ult- including colorectal liver metastases and sound, for the prognosis and assessment of biliary tract carcinomas, while the already liver cancer treatment (including HCC) and published Volumes 1, 2, 3, and 4 detail liver metastases from colorectal cancer are similar aspects of breast, lung, prostate, discussed in detail, as is the use of radiof- gastrointestinal, and colorectal cancer, quency ablation in hepatic tumors. respectively. Approximately 50% of colorectal cancer Surgical resection is the standard therapy (CRC) patients develop liver metastases for resectable liver disease, resulting in during the course of their disease, and 5-year overall survival rates of 20–40%. more than 50% of patients who die of CRC One the other hand, the median overall have liver metastases at autopsy. Regional survival of patients with unresectable liver lymph node (RLN) involvement in patients metastases does not exceed 18–20 months, with colorectal liver metastases is one with a 5-year survival rate approaching of the worst prognostic factors. Recent zero. In other words, there is virtually no studies indicate that for these patients, long-term survival. Both resectable and combined liver resection and pedicular unresectable liver cancers are discussed lymphadenectomy can be recommended, in this volume. The method of selecting when RLN metastases respond to p- patients for resection of hepatic colorectal operative chemotherapy.

Editors and Affiliations

  • Department of Biological Sciences, Kean University, Union, USA

    M. A. Hayat

Bibliographic Information

  • Book Title: Methods of Cancer Diagnosis, Therapy, and Prognosis

  • Book Subtitle: Liver Cancer

  • Editors: M. A. Hayat

  • Series Title: Methods of Cancer Diagnosis, Therapy and Prognosis

  • DOI: https://doi.org/10.1007/978-1-4020-9804-8

  • Publisher: Springer Dordrecht

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Science+Business Media B.V. 2009

  • Hardcover ISBN: 978-1-4020-9803-1Published: 23 April 2009

  • Softcover ISBN: 978-90-481-8204-6Published: 08 October 2010

  • eBook ISBN: 978-1-4020-9804-8Published: 21 April 2009

  • Edition Number: 1

  • Number of Pages: XLIV, 514

  • Topics: Cancer Research, Oncology, Surgical Oncology, Nursing, Radiotherapy

Publish with us

Policies and ethics

Back to top

Search

Navigation